EPHA2 and lung cancer: These NPs were loaded with radiosensitizer NU7441 and chemotherapeutic drug Cisplatin for enhanced chemo-radiotherapy of lung cancer and functionalized with EphA2 antibodies to impart lung cancer cell targeting functionalities to the NPs.